ReviewAn overview of tissue and whole organ decellularization processes
Introduction
Biologic scaffolds composed of extracellular matrix (ECM) are commonly used for a variety of reconstructive surgical applications and are increasingly used in regenerative medicine strategies for tissue and organ replacement. The ECM represents the secreted products of resident cells of each tissue and organ, is in a state of dynamic reciprocity with these cells in response to changes in the microenvironment, and has been shown to provide cues that affect cell migration, proliferation, and differentiation [1], [2], [3], [4], [5], [6], [7]. Preservation of the native ultrastructure and composition of ECM during the process of tissue decellularization is highly desirable [8], [9], [10], [11], [12], [13], [14]. A review of tissue decellularization techniques and their effect upon ECM properties was published in 2006 [15]. However, the development of new decellularization techniques and the advent of three-dimensional whole organ decellularization have since emerged. In addition, the deleterious in vivo effects of residual cellular material are becoming more recognized [16], [17], [18], [19]. The rapid diversification of both decellularization methods and source tissues, and the expanding list of clinical applications suggest that cell residues in ECM should be evaluated objectively against a quantitative definition. The objectives of the present manuscript are (1) to provide an updated overview of tissue and organ decellularization techniques and their expected effects on the mechanical and biological properties of the remaining ECM as determined by systematic investigations [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45] and (2) to define a decellularization standard that has been shown to avoid adverse host responses following implantation and is associated with constructive host responses.
Section snippets
Clinical relevance and rationale for the use of ECM as a biologic scaffold
The use of ECM derived from decellularized tissue is increasingly frequent in regenerative medicine and tissue engineering strategies, with recent applications including the use of three-dimensional ECM scaffolds prepared by whole organ decellularization [8], [9], [10], [46], [47]. Clinical products such as surgical mesh materials composed of ECM are harvested from a variety of allogeneic or xenogeneic tissue sources, including dermis, urinary bladder, small intestine, mesothelium, pericardium,
Decellularization agents
The most effective agents for decellularization of each tissue and organ will depend upon many factors, including the tissue’s cellularity (e.g. liver vs. tendon), density (e.g. dermis vs. adipose tissue), lipid content (e.g. brain vs. urinary bladder), and thickness (e.g. dermis vs. pericardium). It should be understood that every cell removal agent and method will alter ECM composition and cause some degree of ultrastructure disruption. Minimization of these undesirable effects rather than
Techniques to apply decellularization agents
The optimal application of decellularization agents is dependent upon tissue characteristics such as thickness and density, the agents being used, and the intended clinical application of the decellularized tissue. Prior to applying decellularization agents, undesirable excess tissue may be removed to simplify the cell removal process [29], [97]. Tissue removal may focus on retention of key ECM components such as basement membrane. Direct force may also be applied to tissue to aid in
Sterilization of decellularized ECM
It is necessary to sterilize biologic scaffolds composed of ECM prior to implantation or in vitro use, including depyrogenation to eliminate endotoxins and intact viral and bacterial DNA that may be present. Biological scaffolds may be sterilized by simple treatments such as incubation in acids [64] or solvents [60], but such methods may not provide sufficient penetration or may damage key ECM constituents [65]. However, sterilization methods such as ethylene oxide exposure, gamma irradiation,
Evaluation of decellularized ECM
Residual cellular material within ECM may contribute to cytocompatibility problems in vitro and adverse host responses in vivo upon reintroduction of cells [16], [17], [18], [19]. Although decellularization techniques cannot remove 100% of cell material, it is possible to quantitatively assay cell components such as double-stranded DNA (dsDNA), mitochondria, or membrane-associated molecules such as phospholipids. The threshold concentration of residual cellular material within ECM sufficient to
Conclusion
The preparation of biologic scaffold materials composed of mammalian ECM requires decellularization of source tissues. Such decellularization typically involves exposure to selected non-physiologic chemical and biologic agents such as detergents and enzymes and physical forces that unavoidably cause disruption of the associated ECM. Since the source tissues for biologic scaffolds are typically allogeneic or xenogeneic in origin, maximal decellularization is desirable. The choice of
References (125)
- et al.
Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo
Matrix Biol
(2010) - et al.
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth
Eur J Cancer
(2010) - et al.
Matricellular proteins: extracellular modulators of cell function
Curr Opin Cell Biol
(2002) - et al.
Extracellular matrix as a biological scaffold material: structure and function
Acta Biomater
(2009) - et al.
Decellularization of tissues and organs
Biomaterials
(2006) - et al.
Autoimmunity and the clearance of dead cells
Cell
(2010) - et al.
Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component
Biomaterials
(2009) - et al.
The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds
Biomaterials
(2010) - et al.
Process development of an acellular dermal matrix (ADM) for biomedical applications
Biomaterials
(2004) - et al.
Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells
J Thorac Cardiovasc Surg
(2004)
A mechanical evaluation of three decellularization methods in the design of a xenogeneic scaffold for tissue engineering the temporomandibular joint disc
Acta Biomater
The use of high-hydrostatic pressure treatment to decellularize blood vessels
Biomaterials
Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft
Biomaterials
Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves
J Struct Biol
Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity
Biomaterials
Preparation and characterization of decellularized cornea using high-hydrostatic pressurization for corneal tissue engineering
Biomaterials
The use of decellularized adipose tissue to provide an inductive microenvironment for the adipogenic differentiation of human adipose-derived stem cells
Biomaterials
The influence of extracellular matrix derived from skeletal muscle tissue on the proliferation and differentiation of myogenic progenitor cells ex vivo
Biomaterials
Functional skeletal muscle formation with a biologic scaffold
Biomaterials
Collagen fiber alignment and biaxial mechanical behavior of porcine urinary bladder derived extracellular matrix
Biomaterials
Investigations of urothelial cells seeded on commercially available small intestine submucosa
Eur Urol
A comparison of macroscopic lipid content within porcine pulmonary and aortic valves. Implications for bioprosthetic valves
J Thorac Cardiovasc Surg
Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma
Blood
Immune response to biologic scaffold materials
Semin Immunol
Regulation of the fibronectin receptor affinity by divalent cations
J Biol Chem
Structural and functional aspects of calcium binding in extracellular matrix proteins
Matrix Biol
Development of an acellular bioengineered matrix with a dominant vascular pedicle
J Surg Res
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer
Annu Rev Cell Dev Biol
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation
FASEB J
Structure and function of matrix metalloproteinases and TIMPs
Cardiovasc Res
Regulation of wound healing by growth factors and cytokines
Physiol Rev
Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart
Nat Med
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix
Nat Med
Tissue-engineered lungs for in vivo implantation
Science
Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering
Tissue Eng Part A
Adrenal extracellular matrix scaffolds support adrenocortical cell proliferation and function in vitro
Tissue Eng Part A
Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study
J Heart Valve Dis
Regulation of dendritic- and T-cell fate by injury-associated endogenous signals
Crit Rev Immunol
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Nature
RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering
J Mater Sci Mater Med
Development of acellular dermis from porcine skin using periodic pressurized technique
J Biomed Mater Res B Appl Biomater
Developing an articular cartilage decellularization process toward facet joint cartilage replacement
Neurosurgery
Histological evaluation and biomechanical characterisation of an acellular porcine cornea scaffold
Br J Ophthalmol
Comparison of aortic valve allograft decellularization techniques in the rat
J Biomed Mater Res A
Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering
Tissue Eng Part C Methods
Regeneration and orthotopic transplantation of a bioartificial lung
Nat Med
Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction
J Biomed Mater Res
Comparison of different decellularization procedures of porcine heart valves
Int J Artif Organs
Method of preparing a decellularized porcine tendon using tributyl phosphate
J Biomed Mater Res B Appl Biomater
Effect of chemical treatments on tendon cellularity and mechanical properties
J Biomed Mater Res
Cited by (2613)
The application of small intestinal submucosa in tissue regeneration
2024, Materials Today BioEnhancing neuroinduction activity of PLCL-based nerve conduits through native epineurium integration
2024, Biomaterials Advances